232 related articles for article (PubMed ID: 30884095)
1. Development of "CLAN" Nanomedicine for Nucleic Acid Therapeutics.
Xu CF; Iqbal S; Shen S; Luo YL; Yang X; Wang J
Small; 2019 Apr; 15(16):e1900055. PubMed ID: 30884095
[TBL] [Abstract][Full Text] [Related]
2. Optimization of lipid-assisted nanoparticle for disturbing neutrophils-related inflammation.
Liu Y; Cao ZT; Xu CF; Lu ZD; Luo YL; Wang J
Biomaterials; 2018 Jul; 172():92-104. PubMed ID: 29723758
[TBL] [Abstract][Full Text] [Related]
3. Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?
Qiu M; Glass Z; Xu Q
Biomacromolecules; 2019 Sep; 20(9):3333-3339. PubMed ID: 31342740
[TBL] [Abstract][Full Text] [Related]
4. Lipid-based nucleic acid therapeutics with in vivo efficacy.
Sufian MA; Ilies MA
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1856. PubMed ID: 36180107
[TBL] [Abstract][Full Text] [Related]
5. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-Assisted Polymeric Nanoparticles.
Luo YL; Xu CF; Li HJ; Cao ZT; Liu J; Wang JL; Du XJ; Yang XZ; Gu Z; Wang J
ACS Nano; 2018 Feb; 12(2):994-1005. PubMed ID: 29314827
[TBL] [Abstract][Full Text] [Related]
8. Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics.
Ferreira D; Fontinha D; Martins C; Pires D; Fernandes AR; Baptista PV
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751935
[TBL] [Abstract][Full Text] [Related]
9. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
10. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
Iyer AK; Duan Z; Amiji MM
Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
[TBL] [Abstract][Full Text] [Related]
11. Predicting drug loading in PLA-PEG nanoparticles.
Meunier M; Goupil A; Lienard P
Int J Pharm; 2017 Jun; 526(1-2):157-166. PubMed ID: 28438697
[TBL] [Abstract][Full Text] [Related]
12. Polysaccharide-based nucleic acid nanoformulations.
Raemdonck K; Martens TF; Braeckmans K; Demeester J; De Smedt SC
Adv Drug Deliv Rev; 2013 Aug; 65(9):1123-47. PubMed ID: 23680381
[TBL] [Abstract][Full Text] [Related]
13. Copolymers of poly(lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy.
Vijayakumar MR; Muthu MS; Singh S
Expert Opin Drug Deliv; 2013 Apr; 10(4):529-43. PubMed ID: 23316695
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases.
Fattal E; Fay F
Adv Drug Deliv Rev; 2021 Aug; 175():113809. PubMed ID: 34033819
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species-responsive nanoplatforms for nucleic acid-based gene therapy of cancer and inflammatory diseases.
Zhu D; Chen W; Lin W; Li Y; Liu X
Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34116517
[TBL] [Abstract][Full Text] [Related]
16. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
[TBL] [Abstract][Full Text] [Related]
17. Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.
Vaughan HJ; Green JJ; Tzeng SY
Adv Mater; 2020 Apr; 32(13):e1901081. PubMed ID: 31222852
[TBL] [Abstract][Full Text] [Related]
18. Delivery of tacrolimus with cationic lipid-assisted nanoparticles for ulcerative colitis therapy.
Wang JL; Gan YJ; Iqbal S; Jiang W; Yuan YY; Wang J
Biomater Sci; 2018 Jun; 6(7):1916-1922. PubMed ID: 29850666
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery.
Mollé LM; Smyth CH; Yuen D; Johnston APR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1809. PubMed ID: 36416028
[TBL] [Abstract][Full Text] [Related]
20. Peptides for nucleic acid delivery.
Lehto T; Ezzat K; Wood MJA; El Andaloussi S
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
